DrugPatentWatch Database Preview
Drugs in Development Information for Benzoylecgonine
Email this page to a colleague
What is the drug development status for Benzoylecgonine?
Benzoylecgonine is an investigational drug.
There have been 18 clinical trials for Benzoylecgonine.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2001.
The most common disease conditions in clinical trials are Cocaine-Related Disorders, Renal Insufficiency, and Substance-Related Disorders. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), University of Pennsylvania, and Cincinnati MDRU.
Summary for Benzoylecgonine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,611 |
| WIPO Patent Applications | 1,187 |
| Japanese Patent Applications | 484 |
| Clinical Trial Progress | Phase 3 (2001-03-01) |
| Vendors | 16 |
Recent Clinical Trials for Benzoylecgonine
| Title | Sponsor | Phase |
|---|---|---|
| Trial Of NS2359 For The Treatment of Cocaine Dependence | Saniona | Phase 2 |
| Trial Of NS2359 For The Treatment of Cocaine Dependence | The Dana Foundation | Phase 2 |
| Trial Of NS2359 For The Treatment of Cocaine Dependence | University of Pennsylvania | Phase 2 |
Clinical Trial Summary for Benzoylecgonine
Top disease conditions for Benzoylecgonine
Top clinical trial sponsors for Benzoylecgonine
US Patents for Benzoylecgonine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
